Chronic disease management practices and factors associated with health-related quality-of-life for persons with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy
Author(s) -
Qing Zhang,
Zhen Li,
Yujie Hou,
Huibing Dang,
Jianling Chen,
Lixin Liang,
Qian Wang,
Changsong Cao,
Huifang Zhao,
Ruirui Gui,
Yingling Zu,
Jian Zhou,
Fengkuan Yu,
Juan Wang,
Yongping Song,
Yanli Zhang
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-22-158
Subject(s) - medicine , myeloid leukemia , zhàng , tyrosine kinase inhibitor , quality of life (healthcare) , tyrosine kinase , cancer , china , receptor , nursing , political science , law
The main objective of this study was to explore health-related quality of life (HRQoL) profiles, chronic disease management practices and key factors associated with HRQoL in 540 patients with chronic myeloid leukemia in chronic phase (CML-CP) administered tyrosine kinase inhibitors (TKIs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom